Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep788 | Endocrine tumours and neoplasia | ECE2017

Endocrine health problems detected in 764 patients evaluated in a late effects clinic

Pereira Conceicao , Pereira Joana , Dias Daniela , Donato Sara , Salgado Dauarte

Context: Many pediatric cancer survivors have endocrine conditions. After alkylating agents, steroids, methotrexate and radiation, several endocrine dysfunctions may appear. Surveillance for late effects is recommended by worldwide guidelines.Objective: The objective of the study was to describe the endocrine outcomes of 764 patients followed during a 20 years period in our out-patient clinic.Design: The design was a retrospective ...

ea0063p670 | Interdisciplinary Endocrinology 1 | ECE2019

The impact of new technologies in the future of health somatotropin: 100% therapeutic adhesion in oncological pediatric age survivors in the Ipolfg

Sonia Andrade , Filipa Matos , Joana Simoes-Pereira , Conceicao Pereira Maria da

Introduction: The somatotropin deficit is one of the late consequences of cancer treatments. The administration of somatotropin implies treatment with daily injections, which hinders therapeutic adherence. This goal is a challenge for survivors and health professionals. Therapeutic education and new technologies are instruments that favor the training and development of control mechanisms that promote and motivate the behaviorÂ’s change.Objective: To...

ea0049ep887 | Growth hormone IGF axis - basic | ECE2017

Somatropin treatment Supported by NHS: characterization of submitted patients – 2006 to 2016

Bastos Margarida , Mirante Alice , Afonso Caldas , Vasconcelos Carlos , Bacelar Conceicao , Pereira Conceicao , Lopes Lurdes , Fonseca Marcelo , Serra-Caetano Joana , Patricio Miguel , Esteves Cesar Marques , Ferreira Florbela , Braganca Graciete , Raimundo Luisa , Matos Lurdes , Sampaio Lurdes , Fontoura Manuel , Borges Teresa

Introduction: In our country somatropin treatment is supported by the National Health Service. A National Committee (CNNHC) rules and analysis the submission papers of patients with: isolated/multiple somatotropin deficiency (STD), short stature in: renal chronic disease (DRC), small for gestational age (SGA), Turner syndrome (TS) and Prader Willi syndrome (PWS). In adults only isolated somatropin deficiency diagnosed in childhood.Aims: To analyze the ch...

ea0056p728 | Developmental endocrinology | ECE2018

CNNHC: Preliminary results of treatment with recombinant somatropin

Bastos Margarida , Mirante Alice , Marques Bernardo , Caetano Joana Serra , Afonso Caldas , Vasconcelos Carlos , Bacelar Conceicao , Pereira Conceicao , Lopes Lurdes , Fonseca Marcelo , Patricio Miguel , Esteves Cesar , Ferreira Florbela , Braganca Graciete , Raimundo Luisa , Matos Lurdes , Foutoura Manuel , Borges Teresa

Introduction: Treatment with recombinant Somatropin (rSMT) is safe and has greatly improved the approach of children and adolescents with somatropin deficiency (SMTD) and other growth disorders. In our country, rSMT therapy is approved for isolated/multiple somatropin deficiency, small for gestational age (SGA), chronic kidney disease (CKD), Turner syndrome (TS) and Prader Willi syndrome (PWS). A National Commitee (CNNHC) is responsible for the analysis of each case and treatm...

ea0067gp1 | Poster Presentations | EYES2019

Papillary thyroid carcinoma and Graves disease: a case report

Pinheiro Sara Lomelino , Silva Tiago , Pereira Conceicao , Leite Valeriano

Background: Papillary thyroid cancer (PTC) is the most common type of thyroid carcinoma, but it rarely presents as an intrathoracic mass with concurrent hyperthyroidism due to Graves disease.Case presentation: A 73-year-old man presented with weight loss. Imaging by computed tomography (CT) documented a large mediastinal mass in the infrathyroidal space separate from the thyroid gland and pulmonary lesions suggestive of metastases. Neck ultrasound showed...

ea0049ep783 | Endocrine Disruptors | ECE2017

Endocrine dysfunctions associated with Hodgkin Lymphoma treatment

Dias Daniela , Simoes-Pereira Joana , Donato Sara , Pereira Conceicao

Introduction: Hodgkin lymphoma (HL) survivors may develop a range of long-term complications that arise years after therapy. Among these, the endocrine dysfunctions are a major concern. Aim: To investigate the long-term endocrine effects of HL treatment.Methods: Revision of the HL patientsÂ’ medical files who were followed at our Endocrine Late-effects Clinics.Results: We studied 178 patients (86 (48.3%) were female), whose mea...

ea0049ep1142 | Female Reproduction | ECE2017

How far is possible to make a diagnosis of infertility

Dias Daniela , Simoes-Pereira Joana , Donato Sara , Pereira Conceicao

Introduction: Chemotherapy may be an important cause of primary infertility, especially in girls submitted to this therapy at very young ages.Clinical case: A 20-year-old female was diagnosed with acute lymphoblastic leukaemia at the age of 1. She was submitted to chemotherapy: intrathecal methotrexate and cyclophosphamide and i.v. doxorubicin, vincristine, mercaptopurine, asparaginase and bone marrow transplantation at the age of 2. She was ref...

ea0049ep816 | Paediatric endocrinology | ECE2017

Type 1-like diabetes mellitus in an oncological endocrinology unit

Donato Sara , Andrade Sonia , Dias Daniela , Simoes-Pereira Joana , da Conceicao Pereira Maria

Introduction: Asparaginase is a component of chemotherapy regimens used to treat paediatric acute lymphoblastic leukaemia (ALL). One of its well-known side effects is hyperglycaemia which is probably related to hypoinsulinemia. Its incidence rises significantly when associated with corticotherapy. We present two cases of diabetes related to asparaginase and corticoid administration.Case 1: Eleven-year-old girl diagnosed with an ALL. Before treatment she ...